Concepedia

David W. Vredevoogd

DW

Statistics

Publications

13

Citations

1.1K

H-Index

13

Active since

2018

Affiliations

Oncode Institute(Current)

The Netherlands Cancer Institute

Utrecht University

University of Amsterdam

Leiden University Medical Center

David W. Vredevoogd is an author at Oncode Institute specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2018–2024

13

Publications

13

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold

David W. Vredevoogd, Thomas Kuilman, Maarten A. Ligtenberg et al. · Cell · 2019 · 252 citations · Full text

, , +5

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors

Julia Boshuizen, Louise A. Koopman, Oscar Krijgsman et al. · Nature Medicine · 2018 · 215 citations

, , +11

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

Julia Boshuizen, David W. Vredevoogd, Oscar Krijgsman et al. · Nature Communications · 2020 · 115 citations · Full text

A committed tissue-resident memory T cell precursor within the circulating CD8+ effector T cell pool

Lianne Kok, Feline E. Dijkgraaf, Jos Urbanus et al. · The Journal of Experimental Medicine · 2020 · 107 citations · Full text

Tissue patrol by resident memory CD8+ T cells in human skin

Feline E. Dijkgraaf, Tiago R. Matos, Mark Hoogenboezem et al. · Nature Immunology · 2019 · 82 citations · Full text

, , +11

1–5 of 13